Literature DB >> 11951216

Cryotherapy in the treatment of liver metastases from colorectal cancer.

Tara K Sotsky1, Thanjavur S Ravikumar.   

Abstract

Although hepatic resection remains the treatment of choice for metastatic disease to the liver from colorectal cancer, the procedure is only possible for approximately 10% of patients. Ninety percent of patients with liver metastases ultimately die of liver failure. Thus, attention has turned to other, locoregional techniques that may be used alone or in conjunction with resection to increase the eligibility for some type of surgical, potentially curative treatment. One such option is cryotherapy. This review provides technical, physiologic, and outcome information regarding this technique. Semin Oncol 29:183-191. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 11951216     DOI: 10.1053/sonc.2002.31674

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  10 in total

1.  Concepts and preliminary data toward the realization of image-guided liver surgery.

Authors:  David M Cash; Michael I Miga; Sean C Glasgow; Benoit M Dawant; Logan W Clements; Zhujiang Cao; Robert L Galloway; William C Chapman
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

2.  Short- and-long term results of intraoperative radiofrequency ablation of liver metastases.

Authors:  G Navarra; A Ayav; J-C Weber; S L Jensen; C Smadga; J P Nicholls; N A Habib; L R Jiao
Journal:  Int J Colorectal Dis       Date:  2005-04-28       Impact factor: 2.571

Review 3.  Percutaneous image-guided cryoablation: current applications and results in the oncologic field.

Authors:  Roberto Luigi Cazzato; Julien Garnon; Nitin Ramamurthy; Guillaume Koch; Georgia Tsoumakidou; Jean Caudrelier; Francesco Arrigoni; Luigi Zugaro; Antonio Barile; Carlo Masciocchi; Afshin Gangi
Journal:  Med Oncol       Date:  2016-11-11       Impact factor: 3.064

Review 4.  Radiofrequence ablation of liver cancers.

Authors:  Lian-Xin Liu; Hong-Chi Jiang; Da-Xun Piao
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

5.  Angiography for diagnosis and treatment of colorectal cancer.

Authors:  Jin Gu; Zhao-Lai Ma; Ying Li; Ming Li; Guang-Wei Xu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

Review 6.  Current treatment for liver metastases from colorectal cancer.

Authors:  Lian-Xin Liu; Wei-Hui Zhang; Hong-Chi Jiang
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

7.  Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer.

Authors:  Lian-Xin Liu; Wei-Hui Zhang; Hong-Chi Jiang; An-Long Zhu; Lin-Feng Wu; Shu-Yi Qi; Da-Xun Piao
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

Review 8.  Liver-directed therapies for patients with primary liver cancer and hepatic metastases.

Authors:  Cletus A Arciero; Elin R Sigurdson
Journal:  Curr Treat Options Oncol       Date:  2006-09

9.  The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population.

Authors:  R O Illing; J E Kennedy; F Wu; G R ter Haar; A S Protheroe; P J Friend; F V Gleeson; D W Cranston; R R Phillips; M R Middleton
Journal:  Br J Cancer       Date:  2005-10-17       Impact factor: 7.640

Review 10.  Stereotactic ablative radiotherapy for oligometastatic disease in liver.

Authors:  Myungsoo Kim; Seok Hyun Son; Yong Kyun Won; Chul Seung Kay
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.